×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sangamo Rises on Positive Phase I/II Hemophilia Study Data
Yahoo News Singapore
Sangamo (SGMO) and partner Pfizer announce encouraging data from a phase I/II study evaluating their gene therapy candidate for treating...
4 days ago
This Just In: Analysts Are Boosting Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Outlook for This Year
Simply Wall Street
Shareholders in Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) may be thrilled to learn that the analysts have just...
1 week ago
Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
Business Wire
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company...
3 weeks ago
Sangamo Therapeutics' (SGMO) “Buy” Rating Reaffirmed at HC Wainwright
Defense World
Read Sangamo Therapeutics' (SGMO) “Buy” Rating Reaffirmed at HC Wainwright at Defense World.
4 days ago
Earnings call: Sangamo Therapeutics outlines progress and capital strategy
Investing.com
In the recent earnings call for the first quarter of 2024, Sangamo Therapeutics, Inc. (NASDAQ: SGMO) CEO Sandy Macrae presented an update on...
2 weeks ago
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024.
2 weeks ago
What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
Yahoo Finance
Following the downgrade, the consensus from eight analysts covering Sangamo Therapeutics is for revenues of US$37m in 2024, implying a...
1 month ago
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
Business Wire
Showcased 20 presentations at the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of...
2 weeks ago
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Yahoo Finance
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript May 9, 2024 Sangamo Therapeutics, Inc. isn't one of the 30 most...
1 week ago
Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale ...
Business Wire
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today presented pre-clinical data...
2 weeks ago